Stock listing
NASDAQ:WGRX Wellgistics Health, Inc. Stock
Home listing (NASDAQ) of Wellgistics Health, Inc.
Follow Wellgistics Health, Inc. into a list and get an email when it puts out news.

- Ticker
- NASDAQ:WGRX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Jul 15, 2026
Wellgistics Health Appoints Brett Thompson as Chief Technology Officer
Latest news
Wellgistics Health, Inc. on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 21 in the last 12 months · 57 in all · newest Jul 15, 2026 · oldest 2025
- Decks
- 3 decks · latest Sep 8, 2025
Where Wellgistics Health, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:WGRX · Home listing · This page | NASDAQ | United States | USD |
| BOATS:WGRX | BOATS | United States | USD |
Valuation
Statements: 4 quarters to Jun 30, 2026
- Enterprise value
- No market cap
- P/E
- No market cap
- EV/sales
- No market cap
- EV/EBITDA
- No market cap
- Price/book
- No market cap
- Gross margin
- −125.1%
- Operating margin
- −719.3%
- Net margin
- Revenue too small
- Debt to equity
- Negative equity
- Beta vs S&P 500
- Under 6 months of closes
Team and board
Officers
| Officer | Role |
|---|---|
| Prashant Patel | Interim-CEO and Member of the Board |
| Eric Sherb | Interim-CFO and appointed Mr |
| Scott Powell | President |
| Brett Thompson | Chief Technology Officer |
Board
| Director | Role |
|---|---|
| Prashant Patel | Interim-CEO and Member of the Board |
Events
| Quarter | Results |
|---|---|
| Q3 2025 | Nov 19, 2025 |
| Q2 2025 | Aug 19, 2025 |
| Q1 2025 | May 12, 2025 |
| Q4 2024 | Mar 25, 2025 |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2025) | Investor deck | 30 slides | Sep 8, 2025 |
| Investor Presentation (May 2025) | Investor deck | 28 slides | May 15, 2025 |
| Investor Presentation (March 2025) | Investor deck | 17 slides | March 2025 |
Financings
| Raise | Date |
|---|---|
| Public offering of shares of common stock and warrants Announced: about US$5M · US$0.7 a share · Warrants at US$0.7 for 60 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Working capital and general corporate purposes, possibly including operating expenses, R&D, and pending and future acquisitions | Sep 26, 2025 |
| Equity Line of Credit Cancelled: raise Buyers: Hudson Global Ventures, LLC Use of proceeds: To develop programmable liquidity and on-demand financial infrastructure, including XRP as a treasury reserve and real-time payments infrastructure | Aug 14, 2025 |
| Public offering of shares of common stock Closed: US$4M raised · US$4.5 a share · Craft Capital Management LLC +1 Dealers: Craft Capital Management LLC, D. Boral Capital LLC Use of proceeds: General corporate purposes, including working capital, marketing initiatives and capital expenditures | Feb 24, 2025 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 23.3M | 18.1M | 0 | 32.8M |
| Cost of revenue | 33.0M | 16.4M | 0 | 27.0M |
| Gross profit | -9.64M | 1.77M | 0 | 5.75M |
| Research and development | 375 | 1.40K | ||
| Selling, general and administrative | 70.3M | 6.80M | 2.88M | 7.08M |
| Operating income | -81.2M | -6.15M | -2.88M | -3.42M |
| Depreciation and amortization | 192.2K | 1.11M | 0 | 2.09M |
| EBITDA | -81.0M | -5.03M | -2.88M | -1.34M |
| Interest expense | 4.58M | 831.5K | 15.1K | 287.2K |
| Income before tax | -101.3M | -6.86M | -2.90M | -2.74M |
| Net income | -101.3M | -6.86M | -2.90M | -2.74M |
| Earnings per share, basic | -71.33 | -6.60 | -3.24 | -2.90 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash and equivalents | 42.6K | 1.03M | 1.36K | 0 |
| Receivables | 1.14M | 3.75M | 337.0K | |
| Inventory | 1.64M | 9.52M | 0 | |
| Current assets | 2.82M | 15.2M | 338.4K | 0 |
| Goodwill | 14.2M | 16.2M | 0 | |
| Total assets | 30.5M | 57.3M | 338.4K | 0 |
| Accounts payable | 11.7M | 6.33M | 1.04M | 5.25K |
| Current liabilities | 29.8M | 38.0M | 2.89M | 5.25K |
| Long-term debt | 12.6M | 11.5M | 350.0K | |
| Total debt | 24.8M | 25.1M | 700.0K | |
| Total liabilities | 42.9M | 50.6M | 3.24M | 5.25K |
| Shareholders' equity | -12.4M | 6.73M | -2.90M | -5.25K |
| Shares outstanding | 1.42M | 1.04M | 894.4K | 945.0K |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash from operations | -10.9M | -1.22M | -349.1K | 0 |
| Capital spending | -881.5K | -377.3K | 0 | 0 |
| Free cash flow | -10.9M | -1.60M | -349.1K | 0 |
| Cash from investing | -881.5K | 469.1K | ||
| Cash from financing | 10.8M | 1.78M | 350.5K | 0 |
| Share buybacks | 2.84M | |||
| Change in cash | -985.8K | 1.03M | 1.36K | 0 |
Cap table
Built by 6ix from Wellgistics Health, Inc.’s releases · as of Sep 26, 2025
- Common shares
- 51,955,500
- Fully diluted
- 51,955,500
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 51,955,500 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 51,955,500 |
| May 26, 2026 | |
| May 20, 2026 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Surendra K Ajjarapu Other companies: Trxade Group Inc (Director · Since at least Feb 18, 2025); Aspire Biopharma Holdings, Inc. (Chief Executive Officer, Director · Aug 18, 2023 – Aug 18, 2023 · Past); Tevogen Bio Holdings Inc. (CEO and Chairman, Director · Jun 7, 2023 – Jun 7, 2023 · Past); Ocean Biomediacal, Inc. (Director · Sep 14, 2021 – Mar 22, 2023 · Past); Oceantech Acquisitions I Corp (Director · May 27, 2021 – May 27, 2021 · Past); Scienture Holdings, Inc. (Chairman and CEO, Director · Aug 11, 2014 – Jan 5, 2024 · Past); Aemetis, Inc (President, Director · Dec 7, 2007 – Jun 17, 2008 · Past) | Director · Since at least Mar 31, 2026 |
| Eric Sherb Other companies: urban-gro, Inc. (Director · Since at least Feb 18, 2026); Trxade Group Inc (Director · Since at least Oct 7, 2025); Crown Reserve Acquisition Corp. I (CFO, Director · Since at least Sep 26, 2025); Scienture Holdings, Inc. (Chief Financial Officer · Since at least May 15, 2025); Roze AI Inc. (CFO · Apr 3, 2025 – Apr 3, 2025 · Past) | Interim-CFO and appointed Mr · Since at least Oct 13, 2025 |
| Mark DiSiena Other companies: CarParts.com, Inc. (Interim CFO · Since at least Nov 12, 2025); Trxade Group Inc (Chief Financial Officer · Apr 22, 2025 – Apr 22, 2025 · Past); AgEagle Aerial Systems, Inc. (Chief Financial Officer · Dec 1, 2023 – Sep 3, 2024 · Past); Decentral Life, Inc. (CFO & CAO · Nov 1, 2018 – Feb 6, 2019 · Past); Apex Global Brands Inc (Chief Financial Officer · Nov 8, 2010 – Jun 18, 2012 · Past) | CFO · Apr 24, 2025 – Nov 4, 2026 · Past |
| Prashant Patel Other companies: Crown Reserve Acquisition Corp. I (CEO, Director · Since at least Sep 26, 2025); Trxade Group Inc (Chief Executive Officer, Director · Since at least Feb 18, 2025); Scienture Holdings, Inc. (Interim CFO and Director, Director · Aug 11, 2014 – Jan 5, 2024 · Past) | Interim-CEO and Member of the Board · Since at least Oct 13, 2025 |
| Brett Thompson | Chief Technology Officer · Since at least Jul 15, 2026 |
| Scott Powell | President · Since at least Dec 8, 2025 |
| Srini Kalla | CTO of Wellgistics Health · Until Jul 15, 2026 · Past |
Log in to ask 6ix AI your own questions about Wellgistics Health, Inc.